trending Market Intelligence /marketintelligence/en/news-insights/trending/BXqZqVaemKYILDb5yXimzQ2 content esgSubNav
In This List

Sofinnova Partners closes VC fund at €333M

Blog

Banking Essentials Newsletter: 17th April Edition

Blog

Banking Essentials Newsletter: 7th February Edition

Case Study

A Bank Outsources Data Gathering to Meet Basel III Regulations

Podcast

Private Markets 360° | Episode 8: Powering the Global Private Markets (with Adam Kansler of S&P Global Market Intelligence)


Sofinnova Partners closes VC fund at €333M

Sofinnova Partners raised €333 million for its latest healthcare venture capital fund.

Sofinnova Capital IX will target the biopharmaceutical and medical device sectors. Two-thirds of the investments will be placed in European companies and a third in companies outside of Europe, primarily in North America.

Triago acted as placement agent, while Clifford Chance was the legal counsel.

Sofinnova Partners specializes in life sciences and makes investments across development stages.